About Voyager Therapeutics
Voyager Therapeutics, Inc. (Nasdaq: VYGR) is a biotechnology company dedicated to leveraging the power of human genetics to modify the course of – and ultimately cure – neurological diseases. Our pipeline includes programs for Alzheimer’s disease, amyotrophic lateral sclerosis (ALS), Parkinson’s disease, and multiple other diseases of the central nervous system. Many of our programs are derived from our TRACER™ AAV capsid discovery platform, which we have used to generate novel capsids and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous dosing. Some of our programs are wholly owned, and some are advancing with partners including Alexion, AstraZeneca Rare Disease; Novartis Pharma AG; and Neurocrine Biosciences, Inc.. For more information, visit www.voyagertherapeutics.com.
Voyager Therapeutics® is a registered trademark, and TRACER™ is a trademark, of Voyager Therapeutics, Inc.
Job Summary:
Voyager Therapeutics is seeking a Senior Director to join our Corporate and Business Development team. The Senior Director, Corporate & Business Development (BD), will serve as an influential leader to drive partnerships that address unmet neurological needs, deliver innovative medicine, and create value for Voyager stakeholders. They will leverage their scientific and business acumen to promote Voyager technology and capabilities to advance novel CNS therapeutic development. Importantly, they will integrate and communicate scientific, clinical, market, and high-level financial diligence to enable business cases.
Job Summary:
- Lead search, evaluation, and development of external partnering opportunities per Voyager's mission of developing and delivering neurogenetic medicines
- Promote Voyager's novel delivery technologies and medicines in exchange for value creation
- Obtain and communicate market insights through networking, competitive intelligence, and attending conferences
- Wear multiple hats to support internal and external initiatives including a capacity to advance projects and deals forward
- Lead and manage cross-functional due diligence
- Prepare and coordinate high quality documents for management presentations
- Support contract agreements and negotiations for BD and cross-functional colleagues
Knowledge & Skills:
- Deep scientific knowledge and understanding of biopharma industry value chain
- Learning agility for technology innovation, neurological disease and therapeutic landscape, and Voyager’s multi-modality therapeutic strategy
- Experience and/or willingness to work in a fast-paced innovative environment
- Ability to lead multiple initiatives efficiently and collaborate with cross-functional partners to prioritize and meet deadlines
- Proactive, flexible, resourceful and responsive to ongoing business needs
- High level financial acumen to inform BD transaction strategy and Voyager enterprise activities, economic modeling and analysis is a plus
Requirements:
- BA/BS and MS, MBA, or equivalent; Doctorate preferred (PhD, PharmD, MD, etc.)
- 10+ years of professional working experience; 7+ years of which have been within biopharma relevant areas, such as, but not limited to, discovery research, clinical development, strategy and operations, business development, medical affairs, marketing, and/or management consulting
- Exceptional ability to understand scientific landscape, therapeutic modalities, and business implications for key stakeholders of Voyager
- Superb written and verbal communication skills to advance external engagement and internal alignment to execute partnering opportunities
- Track record of successful project management and BD deals demonstrating value creation
- Travel as needed for business needs
- Ability to positively contribute to Voyager values of addressing unmet neurological needs (#patients first), collaboration (#better together), creativity (#transformative innovation), and determination (#disciplined execution)
- Ability to work 3 days onsite at our Lexington, MA offices
What We Do
We are Voyager Therapeutics, a pre-clinical stage biotech compelled by curiosity and powered by persistence. Voyagers are bold innovators who are energized in unlocking the full potential of AAV gene therapy employing our TRACER™ capsid discovery platform. Our resolve is to advance the field of AAV gene therapy, and through our innovative capsids, we are extending the reach and impact of our technology to help more patients in need.
Recognizing that we can expand on the experience, innovation, and outcomes that propel our efforts by working together, we actively seek diverse views. If you’re someone who wants to make discoveries that change the landscape of medicine for patients, we want you on our team!
